As the go-to technique for precisely quantifying nucleic acid targets today, droplet digital PCR originated as a niche method to detect rare cancer causing mutants in the 1990s. Since then, droplet digital PCR has rapidly evolved, advancing gene and cell therapy development and novel drug discovery.
Download this milestone article from Bio-Rad to learn about the invention of droplet digital PCR and how it paved the path to targeted therapeutic development.